Medical insurance can be reimbursed.

The reporter learned from the Shenzhen Medical Security Bureau that the first batch of domestic new crown special pills were sent to Shenzhen and have been put into clinical treatment. This domestic new crown special medicine domestic pricing is basically within 10,000 yuan. The drug is temporarily incorporated into the scope of payment of the medical insurance fund.

Domestic new crown special medicine pricing is less than 10,000 yuan

A few days ago, the long -lasting new crown and antibody "Anbawei's anti -resistance and Lemisvitab" joint therapy was launched in China. On July 9, the first batch of Anbawei's anti -resistance and Romi Siwei were sent to Shenzhen Third People's Hospital. The first batch of drugs totaled 100 people and stored in the cold chain environment of 2-8 ° C. On July 11, the drug transfer was officially completed.

According to reports, a 82 -year -old diagnosis case in the hospital has successfully used the new crown and antibody Anbawei's anti -anti -anti -anti -combined therapy medicine, becoming the first clinical user after the commercialization of the drug. At present, the various immune mechanisms of the elderly have been effectively improved, the amount of virus has decreased sharply, and the effect of medication is more obvious.

It is understood that the dosage of the drug use dose of the "Ambellab and Romi Siweizabi" combination therapy is the highest dose among all approved neutralized antibodies at home and abroad. Weizabi 1000 mg and Romi Siwei Mipidumu 1000 mg is composed of 1000 mg. It adopts intravenous infusion. It is lost for about an hour.

At present, the domestic listing model of Ambellimab and Romi Siwei's combination therapy has adopted an independent pricing model in China. Overseas, the business model of this drug is a government procurement model. For example, at the scale of the US government's procurement of millions of people, the government procurement price per person is $ 1,500 to 2,000.

The domestic pricing price of this domestic new crown special medicine is less than 10,000 yuan.

The scope of payment of the medical insurance fund is temporarily incorporated into the medical insurance fund

The price of nearly 10,000 yuan for this new crown special medicine is a heavy burden for many low -income families. However, the good news is that patients can take medical insurance settlement.

According to the Shenzhen Medical Insurance Bureau, during the epidemic, drugs, diagnosis and treatment items and medical consumables used suspected and diagnosed with new coronary virus infection, in line with the "New Coronary Virus Pneumonia Diagnosis and Treatment Plan (Trial Ninth Edition)", all temporarily included in medical insurance Fund payment scope, cancel the standards of hospitalization, to ensure that patients do not affect medical treatment due to expenses.

Anbawei's anti -anti -anti -anti -anti -anti -anti -anti -counterfeit combination therapy has been included in the "New Coronatte Pneumonic Pneumonia Diagnosis Plan (Trial Ninth Edition)", and the medical insurance fund is paid in accordance with regulations. In addition, other drugs in the diagnosis and treatment plan can be reimbursed through medical insurance.

- END -